Opinion AdvaMed’s CEO dismissed The Bleeding Edge documentary as “entertainment.” He is wrong. By Arundhati Parmar
Opinion At AdvaMed’s annual conference, CMS official to industry: Tell us the truth By Arundhati Parmar
Devices & Diagnostics Digital health and medical device trends (your Health 2.0, AdvaMed previews) on MedHeads By Chris Seper
Devices & Diagnostics With potential medical device tax repeal on horizon, Advamed pushes out targeted ad campaign By Lindsey Alexander
MedCity Influencers AdvaMed 2012 to provide forum for discussion, education, networking By AdvaMed 2012
Devices & Diagnostics AdvaMed: Medical device prices and spending stagnant over 20 years By MassDevice Staff
Devices & Diagnostics 510(k) changes get approval (pending implementation) from AdvaMed By MassDevice Staff
MedCity Influencers, Devices & Diagnostics, Legal Top 5 Compliance Issues for Medtech Firms Transitioning To Data-enabled Solutions By Kristin Havranek, Martin Gomez, Matt Wetzel, Steven Tjoe and Stephanie Philbin
Legal, Devices & Diagnostics, Payers CMS wants to repeal breakthrough device coverage rule, dashing med device industry hopes By Anuja Vaidya
MedCity Influencers, Policy To maximize patient access to care, policies should be modernized to enable the broader digital health landscape By Carlos Nunez M.D.